SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $85,000 | -93.3% | 750,000 | 0.0% | 0.00% | -92.9% |
| Q3 2018 | $1,275,000 | -2.3% | 750,000 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $1,305,000 | -5.0% | 750,000 | 0.0% | 0.01% | +9.1% |
| Q1 2018 | $1,373,000 | -17.9% | 750,000 | 0.0% | 0.01% | -15.4% |
| Q4 2017 | $1,673,000 | -75.5% | 750,000 | -68.2% | 0.01% | -74.5% |
| Q3 2017 | $6,831,000 | -7.5% | 2,355,681 | +42.0% | 0.05% | -17.7% |
| Q2 2017 | $7,382,000 | -7.3% | 1,658,770 | -2.9% | 0.06% | -4.6% |
| Q1 2017 | $7,964,000 | +1642.7% | 1,709,035 | +1609.0% | 0.06% | +242.1% |
| Q3 2013 | $457,000 | +5.8% | 100,000 | 0.0% | 0.02% | -9.5% |
| Q2 2013 | $432,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |